Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.

Abstract

BACKGROUND Hepatocellular carcinoma (HCC) is a leading cause of cancer death, with few treatment options for advanced disease. OBJECTIVES Here, we review the aetiology of HCC and focus on recent data on tumour-associated antigens (TAA) for HCC, their functions and potential use as immunological targets for immune-based therapy for HCC. In addition, we… (More)
DOI: 10.1517/14712598.8.3.325

Topics

Cite this paper

@article{Evdokimova2008AlphafetoproteinAO, title={Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.}, author={Viktoria N. Evdokimova and Lisa H. Butterfield}, journal={Expert opinion on biological therapy}, year={2008}, volume={8 3}, pages={325-36} }